17-beta-hydroxysteroid dehydrogenase deficiency overview
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
17-beta-hydroxysteroid dehydrogenase deficiency overview On the Web |
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency overview |
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency overview |
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency overview |
17-beta-hydroxysteroid dehydrogenase deficiency overview in the news |
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency overview |
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]
Synonyms and keywords: 17-beta hydroxysteroid dehydrogenase III deficiency, 17-ketosteroid reductase deficiency of testis, 17-KSR deficiency, Neutral 17-beta-hydroxysteroid oxidoreductase deficiency, Male Pseudohermaphroditism with gynecomastia, Testosterone 17-beta-dehydrogenase deficiency
Overview
17-beta-hydroxysteroid dehydrogenase deficiency is a rare autososmal recessive developmental disorder that affects male sexual development. The synthesis of testestrone is impaired and the levels in the serum is low which disrupts the formation of external male genitalia before birth. The affected individual is genetically male with XY chromosomes with phenotype female or ambigiounal external genitalia. They are raised as girls.